| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 Oct 24 | OTLK Outlook Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 5.22 | 71,169 | 371.50 k | 71,169 |
| 1 Oct 24 | OTLK Outlook Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 5.22 | 56,636 | 295.64 k | 56,636 |
| 30 Jun 24 | KRYS Krystal Biotech | Stock Option Common Stock | Grant | Acquire A | No | No | 183.64 | 5,000 | 918.20 k | 5,000 |
| 20 May 24 | KRYS Krystal Biotech | Common Stock | Sell | Dispose S | No | No | 165.7576 | 1,980 | 328.20 k | 0 |
| 20 May 24 | KRYS Krystal Biotech | Common Stock | Sell | Dispose S | No | No | 164.3413 | 7,090 | 1.17 mm | 1,980 |
| 20 May 24 | KRYS Krystal Biotech | Common Stock | Sell | Dispose S | No | No | 163.7063 | 10,930 | 1.79 mm | 9,070 |
| 20 May 24 | KRYS Krystal Biotech | Common Stock | Option exercise | Acquire M | No | No | 22.75 | 20,000 | 455.00 k | 20,000 |
| 20 May 24 | KRYS Krystal Biotech | Stock Option Common Stock | Option exercise | Dispose M | No | No | 22.75 | 20,000 | 455.00 k | 0 |
| 1 May 24 | RVNC Revance Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 15,000 | 0.00 | 45,106 |
| 1 May 24 | RVNC Revance Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 3.795 | 23,458 | 89.02 k | 23,458 |
